All In MedTech

FDA Clearance Tracker · P180002

Zephyr Endobronchial Valve System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jun 29, 2018 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product codeBreakthrough

Decided

Jun 29, 2018

Approved

Time to decision

178 days

Received Jan 2, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P180002
Device name
Zephyr Endobronchial Valve System
Applicant location
Redwood City, CA
Received
Jan 2, 2018
Decided
Jun 29, 2018
Decision
Approved
Supplements
29 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NJK

FDA's approval statement

As written in FDA's record.

Approval of the Pulmonx Zephyr® Endobronchial Valve System. The device is an implantable bronchial valve indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NJK (Valve, pulmonary).
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Pulmonx Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.